Relmada Therapeutics, Inc.
RLMD- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001553643
In the last 90 days, Relmada Therapeutics, Inc. insiders filed 2 open-market purchases and 0 sales; 126 institutions reported holding it in 13F filings for Q2 2026, worth $693.7M in total; no superinvestor holds it.
13F holders, Q2 2026
Institutional positions in Relmada Therapeutics, Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 126
- +24 vs. Q1 2026
- Shares held
- 100.2M
- +26.6M (+36.1%) vs. Q1 2026
- Total value
- $693.7M
- +$181.7M (+35.5%) vs. Q1 2026
- New holders
- 47
- 36 more added
- Sold out
- 23
- 22 more reduced
1 institution that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RLMD on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 126 | $693.7M |
| Q1 2026 | 103 | $588.8M |
| Q4 2025 | 78 | $245.8M |
| Q3 2025 | 44 | $15.5M |
| Q2 2025 | 50 | $3.18M |
| Q1 2025 | 44 | $1.68M |
| Q4 2024 | 48 | $4.36M |
| Q3 2024 | 69 | $40.2M |
| Q2 2024 | 79 | $40.7M |
| Q1 2024 | 93 | $66.5M |
| Q4 2023 | 83 | $56.4M |
| Q3 2023 | 88 | $45.0M |
| Q2 2023 | 95 | $39.7M |
| Q1 2023 | 91 | $40.3M |
| Q4 2022 | 110 | $66.8M |
| Q3 2022 | 134 | $953.6M |
| Q2 2022 | 113 | $468.5M |
| Q1 2022 | 113 | $623.1M |
| Q4 2021 | 97 | $467.2M |
| Q3 2021 | 87 | $262.8M |
| Q2 2021 | 85 | $318.3M |
| Q1 2021 | 82 | $335.7M |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Relmada Therapeutics, Inc.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Boxer Capital Management, LLC | 842,106 | $5.83M | 0.44% | 00.0% | Unchanged |
| Vanguard Portfolio Management LLC | 898,198 | $6.22M | 0.00% | +898,198 | New |
| Opaleye Management Inc. | 935,000 | $6.47M | 0.59% | 00.0% | Unchanged |
| Sio Capital Management, LLC | 1,003,562 | $6.94M | 1.19% | +38,562+4.0% | Added |
| Citadel Advisors LLC | 1,061,665 | $7.35M | 0.00% | +1,061,665 | New |
| Polar Capital Holdings Plc | 1,340,428 | $9.28M | 0.03% | −74,193−5.2% | Reduced |
| Commodore Capital LP | 1,425,000 | $9.86M | 0.59% | +791,099+124.8% | Added |
| StemPoint Capital LP | 1,460,093 | $10.1M | 1.75% | +862,684+144.4% | Added |
| Balyasny Asset Management LLC | 1,520,688 | $10.5M | 0.02% | +1,268,231+502.4% | Added |
| Eventide Asset Management, LLC | 1,858,416 | $12.9M | 0.17% | +1,016,310+120.7% | Added |
| Ameriprise Financial Inc | 1,937,972 | $13.4M | 0.00% | +347,026+21.8% | Added |
| Driehaus Capital Management LLC | 2,132,053 | $14.8M | 0.09% | 00.0% | Unchanged |
| Ikarian Capital, LLC | 2,148,359 | $14.9M | 2.43% | −540,000−20.1% | Reduced |
| Marshall Wace, LLP | 2,246,839 | $15.5M | 0.01% | −2,234,767−49.9% | Reduced |
| Millennium Management LLC | 2,361,827 | $16.3M | 0.01% | −1,545,438−39.6% | Reduced |
| Geode Capital Management, LLC | 2,492,573 | $17.3M | 0.00% | +1,643,890+193.7% | Added |
| State Street Corp | 2,517,550 | $17.4M | 0.00% | +2,160,510+605.1% | Added |
| OrbiMed Advisors LLC | 3,631,195 | $25.1M | 0.48% | −1,084,669−23.0% | Reduced |
| Jones Hill Capital LP | 3,655,075 | $25.3M | 5.38% | +3,312,323+966.4% | Added |
| Vanguard Capital Management LLC | 4,460,210 | $30.9M | 0.00% | +1,383,640+45.0% | Added |
| Adage Capital Partners GP, L.L.C. | 4,763,158 | $33.0M | 0.05% | 00.0% | Unchanged |
| Spruce Street Capital LP | 6,391,328 | $44.2M | 8.68% | +129,214+2.1% | Added |
| VR Adviser, LLC | 6,844,305 | $47.4M | 1.44% | +2,000,925+41.3% | Added |
| Squadron Capital Management LLC | 7,350,000 | $50.9M | 17.41% | −1,124,571−13.3% | Reduced |
| BlackRock, Inc. | 7,426,780 | $51.4M | 0.00% | +6,137,230+475.9% | Added |
| Jupiter Topco LLC | 11,164,803 | $77.3M | 0.03% | +11,164,803 | New |
| Ra Capital Management, L.P. | 0 | $0 | 0.00% | −2,947,369−100.0% | Sold out |
| CI Private Wealth, LLC | 0 | $0 | 0.00% | −719,582−100.0% | Sold out |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −504,820−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −221,969−100.0% | Sold out |
| Ally Bridge Group (NY) LLC | 0 | $0 | 0.00% | −210,525−100.0% | Sold out |
| RBF Capital, LLC | 0 | $0 | 0.00% | −120,000−100.0% | Sold out |
| Burkehill Global Management, LP | 0 | $0 | 0.00% | −105,263−100.0% | Sold out |
| Brevan Howard Capital Management LP | 0 | $0 | 0.00% | −73,595−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −63,426−100.0% | Sold out |
| Hillsdale Investment Management Inc. | 0 | $0 | 0.00% | −53,600−100.0% | Sold out |
| Fifth Lane Capital, LP | 0 | $0 | 0.00% | −45,000−100.0% | Sold out |
| Hudson Bay Capital Management LP | 0 | $0 | 0.00% | −42,141−100.0% | Sold out |
| Omers Administration Corp | 0 | $0 | 0.00% | −41,600−100.0% | Sold out |
| Catalyst Funds Management Pty Ltd | 0 | $0 | 0.00% | −34,057−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −33,606−100.0% | Sold out |
| Bank of Nova Scotia | 0 | $0 | 0.00% | −30,600−100.0% | Sold out |
| Diametric Capital, LP | 0 | $0 | 0.00% | −24,006−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −23,247−100.0% | Sold out |
| Jefferies Financial Group Inc. | 0 | $0 | 0.00% | −16,120−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −14,350−100.0% | Sold out |
| Graham Capital Management, L.P. | 0 | $0 | 0.00% | −13,493−100.0% | Sold out |
| Quadrature Capital Ltd | 0 | $0 | 0.00% | −12,498−100.0% | Sold out |
| Farther Finance Advisors, LLC | 0 | $0 | 0.00% | −684−100.0% | Sold out |
| Janus Henderson Group PLC | – | – | – | – | Not filed |